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ABSTRACT
Objective: Metabolic disorders are of growing concern with increasing quest for herbal medicines as a treatment option. The current study is planned 
to screen 10 herbal extracts, prepared from various parts of six herbal plants, to compare and investigate their antihyperglycemic and anorexic 
potential.
Methods: The qualitative phytochemical investigation was done as per the standard procedures. Acute oral toxicity study performed as per the 
Organization for Economic Co-operation and Development 420 guideline. Method optimization of glucose tolerance test (GTT) was done to select 
appropriate glucose load to induce hyperglycemia. Antihyperglycemic activity was evaluated by GTT (single dose and multiple dose study) and food 
intake inhibitory potential was screened by food intake measurement.
Results: All herbs were found safe in acute oral toxicity study. GTT method optimization study signaled use of 3 g/kg glucose load for induction of 
hyperglycemia in single- and multiple-dose studies. In single-dose study, Luffa acutangula fruit extract and in multiple dose study, Solanum melongena, 
Moringa Oleifera, and Ricinus communis extracts were found to produce a significant glucose lowering effect as compared to the glucose control group. 
Results of food intake measurement showed significant appetite suppression with extracts of W. somnifera, S. melongena, M. oleifera, and R. communis.
Conclusion: The present study throws light on the effectiveness of experimental herbal extracts as antihyperglycemic and anorexic agents. This also 
helps in identifying potent indigenous herbs for further study. 
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INTRODUCTION
Metabolic disorders such as diabetes and obesity are associated with 
insulin resistance result into hyperglycemia. Hyperglycemia is the 
main characteristic symptom of diabetes mellitus [1]. Hyperglycemia 
contributes to the poor quality of life, reduced life expectancy, and leads 
to the elevated medical costs [2] and another point of concern is adverse 
effects associated with currently available synthetic anti-diabetic 
drugs [3]. Hyperglycemia leads to 3.7 million deaths per year [4], which 
indicates need to search for new drugs as a treatment option.
Overeating leads to the disease such as obesity [5]. As worldwide, more 
than 70% of adult population is overweight [4], so the eating disorders 
are of growing concern. Drugs such as fenfluramine, rimonabant, 
and sibutramine were approved due to their appetite depressant 
potential, but these drugs were withdrawn from the market due to their 
psychological and cardiovascular adverse effects [6], indicating that 
investigations should be done to find out a safer appetite suppressant.
Herbal medicines are a safe and effective option with fewer side 
effects [7]. There are so many herbal extracts screened till date for 
the treatment of the metabolic disorders such as diabetes and obesity. 
Many of them are well known as per Ayurvedic, Unani, or Siddha system 
of medication. These well-known plants were studied in depth for their 
potential to treat metabolic diseases significantly. On the other side, 
there are so many herbal extracts studied briefly for the treatment of 
few or any one condition associated with metabolic disorders. In this 
study, such herbal extracts are chosen to evaluate and compare their 
antihyperglycemic and appetite depressants potential. The plants 
selected for the study are Luffa acutangula (L.) Roxb., Raphanus sativus 
Linn., Withania somnifera (L.) Dunal, Ricinus communis Linn., Solanum 
melongena Linn., and Moringa oleifera Linn. Azadirachta indica, A. Juss 
is chosen to study as herbal standard (Fig. 1).
MATERIALS AND METHODS
Materials used
Accu-Chek® active Glucometer (Roche Diagnostics, Germany) was 
purchased with Accu-Chek® active strips. Metformin (Glucophage, Sun 
Pharmaceutical Industries Ltd., Vadodara, India) and Rimonabant (Gift 
Sample from Cadila Healthcare Ltd., India) were used as standard drug. 
Herbal plants were collected by field collection.
Experimental animals and ethical approval
Wistar rats of either sex, weighing 200-250 g, were used in this study. 
Animals were housed under standard condition (well ventilated, 
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Fig. 1: Study of herbs for glucose lowering and food intake 
inhibitory activity
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temperature 22±2°C, relative humidity 50-60%, and 12 hr day and 
night cycle). The food consisted of normal rat chow, and water was 
provided ad libitum. The study was conducted in accordance with the 
Committee for the Purpose of Control and Supervision of Experiments 
on Animals (CPCSEA) guidelines, Government of India. The animal 
study protocol was approved by IAEC committee, CPCSEA, Government 
of India (BIP/IAEC/2015/18).
Collection and authentication of herbs
After collection, all herbs were dried and authenticated. L. acutangula 
and R. sativus were authenticated from K.N.K. College of Horticulture, 
Mandsaur (M.P.), India, and authentication of W. somnifera, R. communis, 
S. melongena, M. oleifera, and A. indica was done at Department of 
Botany, Gujarat University, India. Dried herbs were powdered and 
extracted using various methods as mentioned in Table 1.
Phytochemical analysis
Preliminary qualitative phytochemical tests to identify the chemical 
constituents of extracts were carried out according to the standard 
methods [21-23].
Acute oral toxicity study
Single-dose acute oral toxicity study was performed as per the 
Organization for Economic Co-operation and Development 420 
guidelines [24].
Pharmacological screening
For all the methods, 1% carboxymethyl cellulose (CMC) was used as a 
vehicle.
The extracts used for the study are:
•	 Aqueous	extracts	of,	R. sativus stem (RSSAQ), A. indica leaves (AIAQ), 
W. somnifera leaves (WSLAQ), and W. somnifera fruit (WSFAQ)
•	 Ethanolic	extract	of	W. somnifera leaves (WSLETH)
•	 Methanolic	extract	of	L. acutangula fruit (LAFMTH)
•	 Hydroalcoholic	extracts	of	S. melongena fruit (SMHA), M. oleifera 
Pods (MOHA), R. communis roots (RCRHA), and L. acutangula peel 
(LAPHA).
Glucose tolerance test (GTT) (method optimization)
For method optimization study, animals were divided into four groups 
(n=6). Group I - vehicle control was treated with 1% CMC, orally. 
Group II, Group III, and Group IV were treated with different glucose 
loads, that is, 2 g/kg, 3 g/kg, and 4 g/kg orally, respectively. The glucose 
load selected after the optimization study was used for further GTT 
studies.
GTT (single dose study)
In this study, all the animals were divided into XIII groups (n=6), 
that is, Group I - vehicle control (1% CMC), Group II - glucose control 
(glucose, 3 g/kg), Group III, IV, V, VI, VII, VIII, IX, X, XI, and XII were 
treated with RSSAQ, LAPHA, LAFMTH, WSLAQ, WSLETH, WSFAQ, 
RCRHA, MOHA, SMHA, and AIAQ, respectively, and Group XIII - 
metformin treated (100 mg/kg). Treatments were given once orally. All 
the extracts were given at the dose of 400 mg/kg. AIAQ was used as 
herbal standard and metformin as allopathic standard.
After 18 hrs of food deprivation, basal blood glucose was measured 
for randomization. After randomization, treatment was given to all 
the animals as mentioned in the group design and glucose levels were 
measured 1 hr after treatment. Thereafter, oral glucose load was given to 
all the groups except Group I. Blood glucose levels were measured using 
Accu-Chek Active Glucometer Strips at 30, 60, 90, and 120 minutes after 
the oral glucose load [25].
GTT (multiple dose study)
In this study, all the animals were given treatment for 7 days. On the 7th 
day, GTT study was performed. Animal grouping and GTT study were 
done same as mentioned above in GTT (single-dose study).
Food intake measurement
Animals were randomized on the basis of mean food intake (n=3 
trials). After randomization, all animals divided into XII groups (n=6), 
that is, Group I - vehicle control (1% CMC), Group II, III, IV, V, VI, VII, 
VIII, IX, X, and XI treated with RSSAQ, LAPHA, LAFMTH, WSLAQ, 
WSLETH, WSFAQ, RCRHA, MOHA, SMHA, and AIAQ, respectively, and 
Group XII – Rimonabant-treated (10 mg/kg). All the extracts were 
given at the dose of 400 mg/kg. All the treatments were given once 
orally.
Cages were prepared with normal chow and weighed. After 18 hrs 
fasting, test drug or vehicle was administered orally to rats. Immediately 
after the treatment, the animals were put in the cages with pre-weighed 
feed, with free access to food and water. The rats were left in the cage 
for 3 hrs, and then returned to their original cages. All excrement was 
removed and the feed was reweighed [26].
Statistical analysis
Data analysis was done by one-way/two-way ANOVA followed by 
Bonferroni multiple comparison test using GraphPad Prism 5 software. 
The p<0.05 was considered statistically significant. Data are presented 
as mean ± standard error of the mean.
Table 1: List of study plants, extracts, extraction method, and uses
S. No Plant used Plant family Part 
used
Extract used Method of 
extraction
Medicinal uses
1 R. sativus Linn. Brassicaceae Stem Aqueous Cold maceration Antioxidant and radical scavenging activity [8], 
antibacterial [9]
2 L. acutangula (L.) 
Roxb
Cucurbitaceae Fruit Methanolic Soxhletion Antidiabetic and antihyperlipidemic [10], 
antioxidant [11]
3 Peel Hydro-alcoholic Cold maceration α‑amylase	inhibitory	activity	[12]
4 W. somnifera (L.) 
Dunal
Solanaceae Leaf Ethanolic Soxhletion Hypoglycemic and hypolipidemic [13], 
antioxidant [14]5 Leaf Aqueous Cold maceration
6 Fruit Aqueous Cold maceration Antioxidant [14]
7 M. oleifera Linn. Moringaceae Pod Hydroalcoholic Soxhletion Antihypertensive, cholesterol lowering, antidiabetic, 
hepatoprotective [15], antioxidant [16]
8 S. melongena Linn. Solanaceae Fruit Hydroalcoholic Soxhletion Cholesterol lowering [17], antioxidant [18]
9 R. communis Linn. Euphorbiaceae Root Hydroalcoholic Soxhletion Anti-inflammatory and free radical scavenging 
activity [19]
10 A. indica A. Juss Meliaceae Leaf Aqueous Cold maceration Antihyperglycemic [20]
R. sativus: Raphanus sativus, L. acutangula: Luffa acutangula, W. somnifera: Withania somnifera, M. oleifera: Moringa oleifera, S. melongena: Solanum melongena, 
R. communis: Ricinus communis, A. indica: Azadirachta indica
162
Asian J Pharm Clin Res, Vol 10, Issue 12, 2017, 160-165
 Jani and Goswami 
RESULTS
Phytochemical analysis
Results of qualitative phytochemical analysis of the extracts showed the 
presence of flavonoids, glycosides, saponins, and/or tannins.
Acute oral toxicity study
No sign of toxicity was observed during toxicity study. Necropsy study 
revealed that structure abnormality was found to be absent.
GTT (method optimization)
On the basis of the results obtained, 2 g/kg, 3 g/kg, and 4 g/kg glucose 
load were found to increase glucose levels significantly as compared to 
vehicle control. Readings of the area under the curve (AUC0-120) of delta 
glucose indicated a significant increase in AUC0-120 of glucose loaded 
groups as compared to vehicle control (Fig. 2).
glucose in Wistar rats). Values are expressed as mean ± standard error 
of the mean (n=6). Data are analyzed by one-way ANOVA followed 
by Bonferroni multiple comparison test. ***p<0.001 as compared to 
Group I
GTT (Single-dose study)
Results indicate that significant elevation in glucose level was observed 
at 30, 60, 90, and 120 minutes in glucose control group as compared 
to vehicle control (Table 2). In treatment groups, LAPHA-treated group 
showed decreased glucose levels at 30 minutes with a significant 
increase at 60 minutes when compared with the glucose control. 
LAFMTH-treated group showed a significant decrease in glucose 
levels at 30 minutes, as compared to glucose control. WSLAQ group 
showed a significant increase in glucose level at 30, 60, and 90 minutes 
and WSLETH group showed a significant increase in glucose level at 
30 minutes, as compared to the glucose control group. No significant 
change was observed in RSSAQ-, WSFAQ-, RCRHA-, MOHA-, and SMHA-
treated groups. AIAQ-treated group showed significant, increase in 
glucose level at 30 minutes and decrease at 60 minutes as compared 
to glucose control. Metformin-treated group showed a significant 
decrease in glucose level at 30, 60, 90, and 120 minutes as compared 
to glucose control. AUC0-120 readings of delta blood glucose indicated a 
significant increase in AUC0-120 of glucose-treated group as compared to 
vehicle control group. A significant increase in AUC0-120 of WSLAQ group 
was observed while a significant decrease was observed in AUC0-120 of 
metformin-treated group as compared to glucose control group (Fig. 3).
GTT (multiple-dose study)
The results (Table 3) indicate that significant elevation in glucose level 
was observed at 30, 60, and 90 minutes in glucose control group as 
compared to vehicle control. In treatment groups, a significant decrease 
in glucose level was observed in RCRHA-, SMHA-, and metformin-treated 
groups at 30 and 60 minutes and in LAPHA- and MOHA-treated group at 
30 minutes, when compared with glucose control. A significant increase 
in glucose level was observed in RSSAQ-, LAFMTH-, WSLAQ-, WSLETH-, 
and AIAQ-treated groups at 120 minutes and in LAPHA-treated group 
Fig. 2: Glucose tolerance test-method optimization (AUC0-120 of the delta glucose in Wistar rats).  Values are expressed as mean ± standard 
error of the mean (n=6). Data were analyzed by one-way ANOVA followed by Bonferroni multiple comparison test. ***p<0.001 as 
compared to Group I
Table 2: Blood glucose levels at various time points in GTT (single-dose study)
Group Blood glucose concentration in mg/dl (mean±SEM)
Basal (minute) 0 minute 30 minutes 60 minutes 90 minutes 120 minutes
I. Vehicle control 83.2±2.2 86±2.3 93.7±2.9 85.8±1.4 77.5±2.8 74.7±1.7
II. Glucose control (3 g/kg) 87.3±1.8 91.7±1.9 149.8±6+++ 138.5±5.9+++ 118.5±5+++ 105.3±8++
III. Glucose+RSSAQ 82.8±2.7 85.7±2.4 135±10.8 133.8±5.6 116±5.7 110.5±7.4
IV. Glucose+LAPHA 83±2.9 86±3.9 107.8±4.5*** 183±9.79*** 124.7±12 96±6.4
V. Glucose+LAFMTH 81.5±2.1 94.3±2.7 121±2.9** 122.7±5.4 113±6.3 99±4.7
VI. Glucose+WSLAQ 84±2.4 76±0.9 285±16.8*** 273.3±12*** 161±9.4*** 108.5±8.3
VII. Glucose+WSLETH 84.7±1.4 75±2.5 176±8.9** 123.7±3.9 108±4.1 96±2.2
VIII. Glucose+WSFAQ 93.8±5.1 95.7±4.5 136.5±3.8 140.2±4.3 115.3±3 104.8±4.1
IX. Glucose+RCRHA 90.5±3.4 94.3±3.7 134.2±3.2 138.3±2.2 122.2±2.8 106.8±2.1
X. Glucose+MOHA 92.5±1.8 93±2 155.2±4.1 135.2±2.6 130.3±2.5 118.8±1.7
XI. Glucose+SMHA 91.5±1.4 94.2±1.8 135.7±1.5 123.5±1.8 122.7±1.4 111.7±1.5
XII. Glucose+AIAQ 83.5±1.2 101.9±2.6 181±3*** 111.5±2** 110±4.1 99.9±4.5
XIII. Glucose+Metformin 89.7±1.8 75±0.97 91.7±3.9*** 105±4.7*** 98.5±3.6* 85.2±3.5*
Values are expressed as mean±SEM (n=6). Data are analyzed by two-way ANOVA followed by Bonferroni multiple comparison test. +++p<0.001 as compared to Group I, 
*p<0.05, **p<0.01, and ***p<0.001 as compared to Group II. GTT: Glucose tolerance test, SEM: Standard error of the mean, RSSAQ: Aqueous extract of Raphanus sativus 
stem, AIAQ: Aqueous extract of Azadirachta indica leaves, WSLAQ: Aqueous extract of Withania somnifera leaves, WSFAQ: Aqueous extract of Withania somnifera fruit, 
WSLETH: Ethanolic extract of Withania somnifera leaves, LAFMTH: Methanolic extract of Luffa acutangula fruit, SMHA: Hydroalcoholic extract of Solanum melongena fruit, 
MOHA: Hydroalcoholic extract of Moringa oleifera pods, RCRHA: Hydroalcoholic extract of Ricinus communis roots, LAPHA: Hydroalcoholic extract of Luffa acutangula peel
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at 60 minutes, as compared to glucose control group. No significant 
change was observed in WSFAQ-treated group. AUC0-120 readings of 
delta blood glucose (Fig. 4) indicated a significant increase in AUC0-120 
of glucose control group as compared to the vehicle control group, 
whereas a significant decrease was observed in AUC0-120 of RCRHA and 
metformin-treated groups as compared to the glucose control group.
Food intake measurement
Results indicate that the order of % inhibition of food intake is:
Rimonabant>WSLETH>SMHA>RCRHA>WSFAQ>WSLAQ>MOHA> 
LAPHA>RSSAQ.
No effect on food intake inhibition was observed in LAFMTH- and AIAQ-
treated groups (Fig. 5).
DISCUSSION
GTT was developed with the aim to diagnose glucose intolerance 
and type 2 diabetes. This test also determines the tissue insulin 
sensitivity [27,28]. However, as per the pre-clinical studies were 
done, GTT is used as a well-known preliminary screening method for 
detection of the antihyperglycemic potential of drugs in non-diabetic 
animals. In the current study, drugs were screened using various GTT 
models to estimate the possibility of use in diabetes.
Safety of selected plant extracts was confirmed by results of acute 
oral toxicity study. In single-dose and multiple-dose GTT models; 
hyperglycemia was significantly well controlled at various time points in 
L. acutangula fruit extract and S. melongena, M. oleifera, and R. communis 
extracts treated groups, respectively, which indicates that these extracts 
enhance glucose utilization. The possible reason for glucose lowering 
activities of these plant extracts may be the presence of flavonoids 
in all the extracts. It is reported that flavonoids have hypoglycemic 
property [29] and exert a stimulatory effect on insulin secretion, improve 
hyperglycemia, and increase glucose uptake in skeletal muscles [30]. 
Agwaya et al. discussed that medicinal plants possess hypoglycemic 
activity through various mechanisms including improvement in the 
insulin sensitivity of target cells or augmenting glucose-dependent 
insulin secretion. They suggested that active phytochemical compounds 
can produce action through a variety of mechanisms [31].
Fig. 3: Glucose tolerance test – single-dose study (AUC0-120 of the delta blood glucose in Wistar rats).  Values are expressed as mean ± 
standard error of the mean (n=6). Data were analyzed by one-way ANOVA followed by Bonferroni multiple comparison test. +++p<0.001 as 
compared to Group I, ***p<0.001 as compared to Group II
Fig. 4: Glucose tolerance test - multiple-dose study (AUC0-120 of the delta blood glucose in Wistar rats).  Values are expressed as mean ± 
standard error of the mean (n=6). Data were analyzed by one-way ANOVA followed by Bonferroni multiple comparison test. +++p<0.001 as 
compared to Group I, *p<0.05 as compared to Group II
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However, few extracts fail to control glucose level, despite the presence 
of flavonoids, saponins, etc., as well as supporting literature, which 
may be because of either complex reaction between the constituents 
present or less amount of the desired constituent.
The drugs, approved for the treatment of obesity, have focused on 
the food intake inhibitory activity because of overeating as a main 
etiological factor responsible for obesity. Drugs such as fenfluramine, 
sibutramine, rimonabant, and lorcaserin reduce food intake when given 
acutely to lean rodents [32]. Food intake measurement is a model for 
screening of drugs to investigate their food intake inhibitory potential. 
In this model, the possible mechanism of food intake inhibition may be 
the action of the drug through the mediators of central nervous system 
or periphery.
AIAQ extract used as herbal standard on the basis of reported studies 
has failed to give an effective response in any of the selected model, 
suggesting that a detailed investigation is required to detect glucose 
inhibitory and food intake inhibitory potential of AIAQ extract. There is 
a possibility that aqueous extract may be less effective as compared to 
alcoholic/hydroalcoholic extracts.
CONCLUSION
The current study throws light on the selected plants for their glucose 
lowering and food intake inhibitory potential. Such studies help to 
confirm the utility of selected herbal medicines for chronic studies of 
metabolic disorders.
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